FDA Panel Now Includes Peptide Sellers | San Antonio News

The FDA is set to hold a high-stakes meeting next month to debate controversial peptide drugs — but this time, the panel includes doctors and pharmacists who profit from selling them. Once dominated by academics, these panels now feature industry insiders pushing unproven treatments for muscle growth and anti-aging, often disguised as “research chemicals.” Compounding pharmacies are fueling the trend, mixing custom, unapproved meds. Past panels have warned of risks, yet this new group includes clinic owners openly advertising non-FDA-approved injections and hormone therapies — even while promoting them on social media. With Health Secretary Robert F. Kennedy Jr. publicly endorsing peptides and criticizing regulatory panels, the debate has become deeply entangled with money, influence, and the future of wellness regulation. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/efb512af5df8f784